Withdrawal of Track and Trace System for Drug Export Formulations.
The Director General of Foreign Trade has officially withdrawn Para 2.76 from the Handbook of Procedures 2023, which previously outlined the procedure for implementing the Track and Trace system for export consignments of drug formulations.
This change means that the responsibility for implementing the authentication system for drug formulations being exported will now fall under the Ministry of Health and Family Welfare. The implementation will follow the provisions set forth in the Drug Rules of 1945.
This update comes into effect immediately. For more details, exporters should refer to the Ministry of Health and Family Welfare for guidance on the new process.
DGFT
Legal
Company Secretarial
DGFT Notifications
Others
Recent Posts
- Amendment in Export Policy: Key Changes to Chapter 23 of ITC(HS) 2022
- Withdrawal of Track and Trace System for Drug Export Formulations.
- Amendment in Import Policy for CTH 890690 (Chapter 89, ITC HS 2022)
- New RoDTEP Annual Return Filing Module
- DGFT amends Import Policy Condition of Glufosinate Technical
- Introducing the Diamond Imprest Authorisation Scheme: Boosting India’s Diamond Exports.
- Updated Export Policy for Agarwood Products
- Extension of “Free” Import Policy for Tur/Pigeon Peas (Cajanus Cajan) Under ITC (HS) 2022 Until 31st March 2026
FeATURED ARTICLES
Amendment in Export Policy: Key Changes to Chapter 23 of ITC(HS) 2022 The Central Government has made amendments to the…
Withdrawal of Track and Trace System for Drug Export Formulations. The Director General of Foreign Trade has officially withdrawn Para…
Amendment in Import Policy for CTH 890690 (Chapter 89, ITC HS 2022) The Central Government has recently amended the Import…
New RoDTEP Annual Return Filing Module As per Public Notice No. 27/2024-25, the Directorate General of Foreign Trade (DGFT) has…
